In CORAL, 165 IPF patients were given one of three doses of nalbuphine ER to test its ability to reduce cough frequency after six weeks.

guideline on CC in Adults in 2006,4 there has been major progress in the diagnosis, and therapy of this condition but it remains a challenging area with a limited evidence base.5 6 Clinical advances, ...